Type 2 Diabetes and Hypertension as Risk Factors for Advanced Fibrosis in Biopsy Proven Metabolic Dysfunction–Associated Steatotic Liver Disease
Diabetes mellitus and hypertension are key metabolic factors associated with advanced fibrosis. Some cases, classified as cryptogenic SLD, also exhibit significant fibrosis. Consequently, identifying high-risk patients, including those undergoing noninvasive tests for fibrosis, is crucial.
Authors
- Takashi Honda (ORCID: https://orcid.org/0000-0001-8951-0952)
- Tomoaki Takeyama (ORCID: https://orcid.org/0000-0003-2365-9775)
- Masashi Hattori (ORCID: https://orcid.org/0000-0002-6868-0095)
- Shinya Yokoyama (ORCID: https://orcid.org/0000-0002-7814-8828)
- Yosuke Inukai (ORCID: https://orcid.org/0000-0002-6983-9061)
- Hidenori Toyoda (ORCID: https://orcid.org/0000-0002-1652-6168)
- Takanori Ito (ORCID: https://orcid.org/0000-0001-8199-5705)
- Yusuke Ando (ORCID: https://orcid.org/0000-0002-8208-4871)
- Kenta Yamamoto (ORCID: https://orcid.org/0000-0002-5456-2469)
- Masatoshi Ishigami (ORCID: https://orcid.org/0000-0003-0938-631X)
- Hiroki Kawashima (ORCID: https://orcid.org/0000-0002-3720-781X)
- Norihiro Imai (ORCID: https://orcid.org/0000-0002-5865-3245)
- Takahiro Nishikawa (ORCID: https://orcid.org/0000-0003-4600-6902)
- Yoji Ishizu
- Kiyoshi Morita
- Tatsuji Shimizu
Institutions
- Nihonkai General Hospital (JP)
- Kani Tono Hospital (JP)
- Ogaki Municipal Hospital (JP)
- Handa City Hospital (JP)
- Toyota Kosei Hospital (JP)
- Daido University (JP)
- Nagoya University (JP)
Publication Details
- Journal
- Journal of Digestive Diseases
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1111/1751-2980.13325
- Citations
- 6
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.32